Fundraising Fox
🦊/People
Sign in

Eric M. Attias

Investor

Managing Partner, Bio&Med Fund; Co-Managing Partner, Brain AI Fund; Founder at Forepont Capital Partners · Board director at Precision Neuroscience

New York

Find your path to Eric

150 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.

Santo PolitiunlockedEric: together at Bankers Trust (1997)
×2Eric: together at Dresdner Kleinwort Wasserstein
Eric: together at UBP - Union Bancaire Privée
Eric: together at Forepont Capital Partners

About

Eric M. Attias founded Forepont in 2017 and serves as managing partner of its Bio&Med Fund and co-managing partner of its Brain AI Fund. He has an investment and company-building background that includes early investments in Synchron and Precision Neuroscience, as well as building, acquiring, and selling companies such as Nexar (sold to UBP) and stakes tied to Allianz's AAAM and Ermitage. He previously managed a large alternative investment company and holds degrees in computer science (neural networks), engineering, and business administration.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Precision Neuroscience

Intro paths

→

In turn, Eric can intro founders to Precision Neuroscience's investors below.

Precision Neuroscience's investors · 6

Alumni VenturesManchester · $100K – $10M checksB Capital GroupManhattan Beach · $10M – $50M checks · since 2024Basecamp FundManchester · $100K – $10M checksForepont Capital PartnersNew YorkSCI VenturesLondon · since 2025Steadview CapitalSan Francisco · since 2021

Co-founders at Precision Neuroscience

BRBenjamin Rapoport
Benjamin RapoportPresident, Chief Science Officer
MMMichael Mager
Michael MagerChief Executive Officer

Experience

  1. Forepont Capital PartnersFoundercurrent2017 — presentNew York, United States
  2. UBP - Union Bancaire PrivéeNEXAR | Founder | Sold to bank UBP|2009 — 2015New York, United States
  3. AllianzNEXAR acquires Allianz Alternative Group (AAAM) from Allianz2010
  4. Caledonia Private CapitalNEXAR acquires Ermitage from Caledonia2010
  5. Nexar GroupNEXAR | Co-Founder | Chief Executive LLC | Chief Investment | Acquired by UBP |2009New York, London, Jersey, Luxembourg, Paris
  6. Societe GeneraleSG Asset Management Inc | Founder | Chief Executive | Chief Investment |2002 — 2009United States
  7. Dresdner Kleinwort WassersteinInvestment Bank Board - ExCo | Department Head | Emerging Markets |1997 — 2002New York | London | Frankfort |
  8. Bankers TrustEM senior Trader1996 — 1997London Area, United Kingdom

Investments

Investor

Precision NeuroscienceSynchron

Per the firm's website.

Colleagues at Forepont Capital Partners

A. Cheikh Lahlou
Senior Advisor at Forepont Capital Partners
Ali Cheikh Lahlou
Investor at Forepont Capital Partners
Brian Schappert
Senior Vice President, Head of U.S. Intermediary Distribution at American Century Private Investments
Bruce Greenberg
Partner at Forepont Capital Partners
David Norton
Board member at Forepont Capital Partners
David Putrino
Venture Partner at Forepont Capital Partners
Doug Siekierski
Investor at Forepont Capital Partners
Doug Weber
Venture Partner at Forepont Capital Partners

Frequently asked questions

Who is Eric M. Attias?
Eric M. Attias founded Forepont in 2017 and serves as managing partner of its Bio&Med Fund and co-managing partner of its Brain AI Fund. He has an investment and company-building background that includes early investments in Synchron and Precision Neuroscience, as well as building, acquiring, and selling companies such as Nexar (sold to UBP) and stakes tied to Allianz's AAAM and Ermitage. He previously managed a large alternative investment company and holds degrees in computer science (neural networks), engineering, and business administration.
Where does Eric M. Attias work?
Eric M. Attias is Managing Partner, Bio&Med Fund; Co-Managing Partner, Brain AI Fund; Founder at Forepont Capital Partners and Board director at Precision Neuroscience.
What does Eric M. Attias invest in?
Eric M. Attias invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What companies has Eric M. Attias invested in?
Investments tracked here include Precision Neuroscience, Synchron.
Where did Eric M. Attias go to school?
Eric M. Attias studied at Columbia University (Master of Business Administration); London Business School (PE & VC Executive Program); Massachusetts Institute of Technology (PhD (ABD)).

Same school

Shared employers